Eisenstein, M. Single-cell RNA-seq analysis software providers scramble to offer solutions.
Nat Biotechnol 38, 254–257 (2020).
A raft of tools have sprung up to help biologists work through the single-cell transcriptomic bottleneck, but integration remains elusive.
The market for single-cell analytical technologies is booming: from a value of $1.83 billion in 2018, it could triple by 2025, according to a report from ResearchAndMarkets.com published last year. The research community’s enthusiastic embrace of single-cell RNA-seq has already transformed the fortunes of some instrument and kit manufacturers. 10X Genomics CEO Serge Saxonov, in a Q3 earnings call from November 2019, announced that the near-term market for his company’s technologies for single-cell analysis could reach $13 billion. But this rapid uptake could also create headaches for new users as they learn how to come to grips with the complexities of single-cell data.